Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study)

Despite the availability of effective antimicrobials, tuberculosis (TB) is still a serious health threat. Mortality is even higher in people living with HIV who are diagnosed with TB. New therapies are needed to shorten the time required to cure TB and decrease fatality rates in this population. N-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Safe, Izabella Picinin, Lacerda, Marcus Vinícius Guimarães, Printes, Vitoria Silva, Praia Marins, Adriana Ferreira, Rebelo Rabelo, Amanda Lia, Costa, Amanda Araújo, Tavares, Michel Araújo, Jesus, Jaquelane Silva, Souza, Alexandra Brito, Beraldi-Magalhães, Francisco, Neves, Cynthia Pessoa, Monteiro, Wuelton Marcelo, Sampaio, Vanderson Souza, Amaral, Eduardo P., Gomes, Renata Spener, Andrade, Bruno B., Cordeiro-Santos, Marcelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319340/
https://www.ncbi.nlm.nih.gov/pubmed/32589648
http://dx.doi.org/10.1371/journal.pone.0235381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319340/
https://www.ncbi.nlm.nih.gov/pubmed/32589648
http://dx.doi.org/10.1371/journal.pone.0235381

Ejemplares similares